Dec 7
|
Repligen's (NASDAQ:RGEN) investors will be pleased with their impressive 158% return over the last five years
|
Dec 7
|
Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements
|
Dec 1
|
Why Is Exact Sciences (EXAS) Up 2.5% Since Last Earnings Report?
|
Nov 30
|
Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue?
|
Nov 15
|
Does Repligen Corp. (RGEN) Have a Bright Future?
|
Nov 14
|
UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
|
Nov 14
|
Repligen Announces Publication of the Company’s 2022 Sustainability Report
|
Sep 12
|
Repligen Appoints Jason K. Garland as Chief Financial Officer
|
Sep 6
|
Reasons For the Decline of Repligen Corporation (RGEN)
|
Aug 10
|
Multiple Headwinds Impacted Repligen Corp. (RGEN)’s Performance in Q2
|
Aug 9
|
News Flash: 14 Analysts Think Repligen Corporation (NASDAQ:RGEN) Earnings Are Under Threat
|
Jul 10
|
Are Options Traders Betting on a Big Move in Repligen (RGEN) Stock?
|
Apr 26
|
Will AnaptysBio, Inc. (ANAB) Report Negative Q1 Earnings? What You Should Know
|
Apr 25
|
Why Repligen Stock Is Sinking Today
|
Apr 25
|
Repligen (RGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
|